This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Whence the pib in all these names? — Preceding unsigned comment added by 12.171.88.10 (talk) 18:59, 14 December 2011 (UTC)[reply]
I'm guessing it has been "unofficially adopted" as the nonproprietary name (INN) stem for CETP inhibitors, like -coxib for COX 1/2 inhibitors. I can't find it in the online version of the "stem book" [[1]], so I'm guessing that it's either not been formalized by whatever body updates the INN system.. Who makes changes in INN stem naming conventions "official" anyway?
Updated versions of "stem book" are published by WHO: [[2]] but it looks like 2011 version doesn't have -cetrapib.Teaktl17 (talk) 05:02, 20 May 2012 (UTC)[reply]
-cetrapib is present on USAN stem list [3] approved by USAN Council.Teaktl17 (talk) 06:31, 20 May 2012 (UTC)[reply]